S-1/A: Greenlane Holdings Files Amendment No. 1 to Form S-1 for Share Resale by Selling Stockholders

Greenlane Holdings has filed an amendment to its Form S-1 registration statement, covering the offering and resale of up to 7,090,911 shares of common stock by selling stockholders.

Summary

• Greenlane Holdings, Inc. filed an amendment to its Form S-1 registration statement on September 6, 2024.
• The filing concerns the offering and resale of up to 7,090,911 shares of common stock by selling stockholders.
• These shares include 58,000 shares of common stock, 2,305,637 shares issuable upon exercise of pre-funded warrants, and 4,727,274 shares issuable upon exercise of outstanding warrants.
• Greenlane will not receive any proceeds from the sale of these shares by the selling stockholders, but will receive proceeds upon any cash exercise of the warrants, for an aggregate of approximately $11,820,490.
• The selling stockholders may sell their shares directly or through underwriters, broker-dealers, or agents.
• The company's common stock is listed on The Nasdaq Global Market under the symbol GNLN, with the last reported sale price on September 5, 2024, at $5.05 per share.
• Investing in Greenlane's securities involves a high degree of risk, as detailed in the Risk Factors section of the prospectus.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it highlights growth opportunities in the cannabis industry and Greenlane's strategic initiatives, it also acknowledges significant risks, financial challenges, and regulatory uncertainties. The company's past financial performance and potential need for additional capital raise concerns.

Positives

• Potential influx of $11,820,490 to Greenlane upon cash exercise of warrants.
• Registration allows selling stockholders to offer shares for resale, potentially increasing liquidity.

Negatives

• Greenlane will not receive any proceeds from the selling stockholders resale of shares.
• The company's stock price has been volatile and has declined significantly since its initial public offering.
• Investing in Greenlane's securities involves a high degree of risk.

Risks

• Global economic conditions, including inflation and supply chain disruptions, could materially and adversely affect the business.
• The company's ability to fund its capital requirements depends on various factors, and failure to increase sales and generate positive cash flows may require further cost reductions.
• Failure to meet Nasdaq listing standards could result in delisting, negatively impacting the liquidity of the company's Class A common stock.
• Narrow margins may magnify the impact of variations in operating costs and adverse events on operating results.
• The market for vaporizer products and related items is a niche market subject to uncertainty and is still evolving.
• The company depends on third-party suppliers for its products and may experience supply shortages.
• A significant percentage of revenue is dependent on sales of products from a relatively small number of key suppliers.
• There is uncertainty related to the regulation of vaporization products and certain other consumption accessories.
• The company is vulnerable to third-party transportation risks, including governmental laws and common carriers policies that prevent the shipment of the types of products it sells.
• The company does not have long-term agreements or guaranteed price or delivery arrangements with most of its suppliers.
• The company does not have long-term contracts with many of its customers, and agreements generally do not commit customers to any minimum purchase volume.
• The company's principal asset is its interest in the Operating Company, and it depends on distributions from the Operating Company to pay its taxes and expenses.
• The Tax Receivable Agreement may require the company to make cash payments to the members of the Operating Company in respect of certain tax benefits to which it may become entitled.
• The company may be subject to audits of its income, sales, and other transaction taxes by U.S. federal, state, local, and foreign taxing authorities.
• The company is subject to increasing international control and regulation.
• The company is transitioning its business and has engaged, and may continue in engage in, dispositions via sales of its assets or other exit activities and other strategic initiatives and it may face risks related to such transactions.
• The company is subject to risks associated with public health crises, such as pandemics and epidemics, which may have a material adverse effect on its business.
• The market price of the company's Class A common stock has been volatile and has declined significantly since its initial public offering and may face more volatility and price declines in the future.
• The company is a smaller reporting company under federal securities laws and it cannot be certain whether the reduced reporting requirements applicable to such companies will make its Class A common stock less attractive to investors.

Future Outlook

Greenlane intends to leverage its competitive strengths to increase shareholder value through core strategies, including accelerating the path to profitability, developing a world-class portfolio of products, and enhancing operating margins.

Management Comments

• Management believes that technology enhancements, facility footprint rationalization, headcount reduction, cost structure optimization, inventory management, sales force upgrade, product innovation, and capital investment will significantly reduce costs, help accelerate the Company's path to profitability, support business growth, and allow the Company to reinvest capital into its highest demand and highest potential product lines.

Industry Context

The document provides context on the cannabis industry's growth and regulatory landscape in the United States, Canada, and Europe, highlighting legislative changes, medical advancements, consumer trends, and economic benefits driving the industry's expansion.

Comparison to Industry Standards

• The U.S. legal cannabis market generated $26.5 billion in 2022, increasing to $31.4 billion in 2023, reflecting an 18.5% growth, according to the XYZ Cannabis Market Report 2023.
• The number of U.S. states with legalized cannabis increased from 18 in 2022 to 23 in 2023, a 27.8% rise in state participation, as per National Cannabis Industry Association Reports.
• The Canadian market grew from CAD 4.8 billion in 2022 to CAD 5.6 billion in 2023, marking a 16.7% increase, according to Government of Canada, Cannabis Market Reports.
• Europe's legal cannabis market also saw significant growth, with revenues rising from 2.1 billion in 2022 to 2.5 billion in 2023, a 19% increase, according to Prohibition Partners Europe Cannabis Report 2023.

Management Changes

Legal Proceedings

• On February 8, 2023, the company filed a lawsuit against Blum in Superior Court of California, Orange County, seeking to compel the repayment of Blums open balance due to the company.

Related Party Transactions

• The company sold $0.0 million and $0.4 million in products and supplies to Blum Holdings, Inc. (Blum) in the years ended December 31, 2023 and 2022, respectively.
• Total gross accounts receivable due from Blum were approximately $0.4 million and $0.4 million as of December 31, 2023 and 2022, respectively.
• Three individuals who were employees of the company at the time are principals in Synergy Imports, LLC the Lender on the Secured Bridge Loan taken out on September 22, 2023, however, none are executive officers or directors of the company.
• Adam Schoenfeld, co-founder and a former director of the company, has a significant ownership interest in one of our customers, Universal Growing.
• Renah Persofsky, a director of the company, is a member of the board of directors of Tilray Brands, Inc. (Tilray).
• Net sales to Tilray totaled approximately $2.2 million, for the year ended December 31, 2022, respectively.

Stakeholder Impact

• Shareholders face potential dilution and volatility in stock price.
• Employees may experience uncertainty due to cost-cutting measures and potential restructuring.
• Customers could be affected by supply chain disruptions and changes in product offerings.
• Suppliers may face increased scrutiny and pressure to comply with regulations.
• Creditors face risks associated with the company's ability to repay debts.

Next Steps

• Selling stockholders may offer shares for resale from time to time.
• The company will continue to implement its remediation plan to address the identified material weaknesses.
• The company will continue to seek opportunities for securing investment capital to leverage its platform, increase availability and reduce stockouts of its high demand third-party brands, invest in marketing and sales, and improve its product offerings.

Key Dates

Keywords

Greenlane Holdings, common stock, selling stockholders, resale, warrants, pre-funded warrants, PIPE, registration statement, GNLN, securities